calgb.org > Clinical Trials
|
|
| CALGB Clinical Trials Information |
The Cancer and Leukemia Group B (CALGB) is a national clinical research group sponsored by the National Cancer Institute, with its Central Office headquartered at the University of Chicago and its Statistical Center located at Duke University. The CALGB was founded in 1956 with a goal of bringing together clinical oncologists and laboratory investigators to develop better treatments for cancer. Since 1956, CALGB has grown into a national network of 26 university medical centers, over 225 community hospitals and more than 3000 oncology specialists who collaborate in clinical research studies aimed at reducing the morbidity and mortality from cancer, relating the biological characteristics of cancer to clinical outcomes and developing new strategies for the early detection and prevention of cancer.
We conduct trials in areas that include:
- Breast
- Cancer in the Elderly
- Correlative Sciences for Solid Tumors
- Economic Implications of Cancer
- Gastrointestinal
- Genitourinary
- Leukemia
- Leukemia Correlative Sciences
- Lymphoma
- Melanoma
- Pharmacology and Experimental Therapeutics
- Quality of Life
- Respiratory
- Surgery
- Stem Cell Transplant
|
A list of publications is available in the Publications section.
Watch "The Importance of Clinical Trials" with featured expert Dr. Richard Schilsky (requires QuickTime)
|
| Search for Active Clinical Trials in CALGB |
To search for clinical trials (CALGB trials and non-CALGB trials), search the NCI's clinical studies database.
The Coalition of National Cancer Cooperative Groups' TrialCheck (a search tool that quickly queries and screens approximately 500 Cooperative Group cancer clinical trials available to health care professionals including patient advocates.)
|
